The role of macrophage migration inhibitory factor in anesthetic-induced myocardial preconditioning

PLoS One. 2014 Mar 25;9(3):e92827. doi: 10.1371/journal.pone.0092827. eCollection 2014.

Abstract

Introduction: Anesthetic-induced preconditioning (AIP) is known to elicit cardioprotective effects that are mediated at least in part by activation of the kinases AMPK and PKCε as well as by inhibition of JNK. Recent data demonstrated that the pleiotropic cytokine macrophage migration inhibitory factor (MIF) provides cardioprotection through activation and/or inhibition of kinases that are also known to mediate effects of AIP. Therefore, we hypothesized that MIF could play a key role in the AIP response.

Methods: Cardiomyocytes were isolated from rats and subjected to isoflurane preconditioning (4 h; 1.5 vol. %). Subsequently, MIF secretion and alterations in the activation levels of protective kinases were compared to a control group that was exposed to ambient air conditions. MIF secretion was quantified by ELISA and AIP-induced activation of protein kinases was assessed by Western blotting of cardiomyocyte lysates after isoflurane treatment.

Results: In cardiomyocytes, preconditioning with isoflurane resulted in a significantly elevated secretion of MIF that followed a biphasic behavior (30 min vs. baseline: p = 0.020; 24 h vs. baseline p = 0.000). Moreover, quantitative polymerase chain reaction demonstrated a significant increase in MIF mRNA expression 8 h after AIP. Of note, activation of AMPK and PKCε coincided with the observed peaks in MIF secretion and differed significantly from baseline.

Conclusions: These results suggest that the pleiotropic mediator MIF is involved in anesthetic-induced preconditioning of cardiomyocytes through stimulation of the protective kinases AMPK and PKCε.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Animals
  • Cardiotonic Agents / pharmacology*
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Gene Expression Regulation / drug effects
  • Intramolecular Oxidoreductases / metabolism*
  • Isoflurane / pharmacology*
  • Macrophage Migration-Inhibitory Factors / metabolism*
  • Muscle Proteins / metabolism*
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism*
  • Protein Kinases / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Anesthetics, Inhalation
  • Cardiotonic Agents
  • Macrophage Migration-Inhibitory Factors
  • Muscle Proteins
  • Isoflurane
  • Protein Kinases
  • Intramolecular Oxidoreductases
  • Mif protein, rat

Grants and funding

This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grants Be1977/4-2 (TP1 of DFG-FOR809), DFG-IRTG1508/1-P13 and Ra969/6-1 to JB, and by a Rotation Program- and START Program grant of the Medical School of RWTH Aachen University to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.